Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1323.2000 9.90 (0.75%)

NSE Jun 19, 2025 14:58 PM

29.73% Gain from 52W Low

Volume: 1.2M

Dr. Reddy's Laboratories Ltd.

29 Oct 2022

1323.20

0.75%

Dr Reddy's Labs (HOLD): US launch of gRevlimid buoys quarter

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

Q2 revenue up 9% YoY on sales of gRevlimid in the US; gross margin expansion aids EBITDA growth of 42% YoY

Dr. Reddy's Laboratories Ltd. is trading above all available SMAs